10 20 30 40 50 60 70 80 1EHQ - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 22-FEB-00 1EHQ
TITLE MODEL OF (+)-COCAINE-BOUND BCHE COMPLEX
CAVEAT 1EHQ CHIRALITY ERROR AT THE CA CENTER OF ASP 1.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: BUTYRYLCHOLINE ESTERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.1.1.8
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN
KEYWDS PROTEIN-COMPOUND COMPLEX
EXPDTA THEORETICAL MODEL
AUTHOR H.SUN,J.EL YAZAL,W.S.BRIMIJOIN,Y.P.PANG
REVDAT 1 08-AUG-01 1EHQ 0
JRNL AUTH H.SUN,J.EL YAZAL,O.LOCKRIDGE,L.M.SCHOPFER, JRNL AUTH 2 S.BRIMIJOIN,Y.P.PANG JRNL TITL PREDICTED MICHAELIS-MENTEN COMPLEXES OF JRNL TITL 2 COCAINE-BUTYRYLCHOLINESTERASE. ENGINEERING JRNL TITL 3 EFFECTIVE BUTYRYLCHOLINESTERASE MUTANTS FOR JRNL TITL 4 COCAINE DETOXICATION. JRNL REF J.BIOL.CHEM. V. 276 9330 2001 JRNL REFN ASTM JBCHA3 US ISSN 0021-9258
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1EHQ COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-FEB-2000. REMARK 100 THE RCSB ID CODE IS RCSB010585.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 482 REMARK 465 GLN A 483 REMARK 465 ASN A 484 REMARK 465 ASN A 485 REMARK 465 SER A 486
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 440 CD GLU A 440 OE2 0.101 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 20 -113.06 43.66 REMARK 500 SER A 197 -118.22 54.17 REMARK 500 GLU A 324 -72.40 66.02 REMARK 500 TRP A 375 -37.78 68.86 REMARK 500 ASN A 454 125.86 65.53 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 251 SER A 252 149.08 REMARK 500 PHE A 297 LEU A 298 148.72
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EHO RELATED DB: PDB REMARK 900 1EHO CONTAINS THE SAME PROTEIN COMPLEXED WITH (+)-COCAINE.
DBREF 1EHQ A 1 531 UNP P06276 CHLE_HUMAN 30 560
SEQADV 1EHQ ASN A 128 UNP P06276 ASP 157 CONFLICT SEQADV 1EHQ TYR A 131 UNP P06276 PHE 160 CONFLICT
SEQRES 1 A 531 ASP ASP ILE ILE ILE ALA THR LYS ASN GLY LYS VAL ARG SEQRES 2 A 531 GLY MET ASN LEU THR VAL PHE GLY GLY THR VAL THR ALA SEQRES 3 A 531 PHE LEU GLY ILE PRO TYR ALA GLN PRO PRO LEU GLY ARG SEQRES 4 A 531 LEU ARG PHE LYS LYS PRO GLN SER LEU THR LYS TRP SER SEQRES 5 A 531 ASP ILE TRP ASN ALA THR LYS TYR ALA ASN SER CYS CYS SEQRES 6 A 531 GLN ASN ILE ASP GLN SER PHE PRO GLY PHE HIS GLY SER SEQRES 7 A 531 GLU MET TRP ASN PRO ASN THR ASP LEU SER GLU ASP CYS SEQRES 8 A 531 LEU TYR LEU ASN VAL TRP ILE PRO ALA PRO LYS PRO LYS SEQRES 9 A 531 ASN ALA THR VAL LEU ILE TRP ILE TYR GLY GLY GLY PHE SEQRES 10 A 531 GLN THR GLY THR SER SER LEU HIS VAL TYR ASN GLY LYS SEQRES 11 A 531 TYR LEU ALA ARG VAL GLU ARG VAL ILE VAL VAL SER MET SEQRES 12 A 531 ASN TYR ARG VAL GLY ALA LEU GLY PHE LEU ALA LEU PRO SEQRES 13 A 531 GLY ASN PRO GLU ALA PRO GLY ASN MET GLY LEU PHE ASP SEQRES 14 A 531 GLN GLN LEU ALA LEU GLN TRP VAL GLN LYS ASN ILE ALA SEQRES 15 A 531 ALA PHE GLY GLY ASN PRO LYS SER VAL THR LEU PHE GLY SEQRES 16 A 531 GLU SER ALA GLY ALA ALA SER VAL SER LEU HIS LEU LEU SEQRES 17 A 531 SER PRO GLY SER HIS SER LEU PHE THR ARG ALA ILE LEU SEQRES 18 A 531 GLN SER GLY SER PHE ASN ALA PRO TRP ALA VAL THR SER SEQRES 19 A 531 LEU TYR GLU ALA ARG ASN ARG THR LEU ASN LEU ALA LYS SEQRES 20 A 531 LEU THR GLY CYS SER ARG GLU ASN GLU THR GLU ILE ILE SEQRES 21 A 531 LYS CYS LEU ARG ASN LYS ASP PRO GLN GLU ILE LEU LEU SEQRES 22 A 531 ASN GLU ALA PHE VAL VAL PRO TYR GLY THR PRO LEU SER SEQRES 23 A 531 VAL ASN PHE GLY PRO THR VAL ASP GLY ASP PHE LEU THR SEQRES 24 A 531 ASP MET PRO ASP ILE LEU LEU GLU LEU GLY GLN PHE LYS SEQRES 25 A 531 LYS THR GLN ILE LEU VAL GLY VAL ASN LYS ASP GLU GLY SEQRES 26 A 531 THR ALA PHE LEU VAL TYR GLY ALA PRO GLY PHE SER LYS SEQRES 27 A 531 ASP ASN ASN SER ILE ILE THR ARG LYS GLU PHE GLN GLU SEQRES 28 A 531 GLY LEU LYS ILE PHE PHE PRO GLY VAL SER GLU PHE GLY SEQRES 29 A 531 LYS GLU SER ILE LEU PHE HIS TYR THR ASP TRP VAL ASP SEQRES 30 A 531 ASP GLN ARG PRO GLU ASN TYR ARG GLU ALA LEU GLY ASP SEQRES 31 A 531 VAL VAL GLY ASP TYR ASN PHE ILE CYS PRO ALA LEU GLU SEQRES 32 A 531 PHE THR LYS LYS PHE SER GLU TRP GLY ASN ASN ALA PHE SEQRES 33 A 531 PHE TYR TYR PHE GLU HIS ARG SER SER LYS LEU PRO TRP SEQRES 34 A 531 PRO GLU TRP MET GLY VAL MET HIS GLY TYR GLU ILE GLU SEQRES 35 A 531 PHE VAL PHE GLY LEU PRO LEU GLU ARG ARG ASP ASN TYR SEQRES 36 A 531 THR LYS ALA GLU GLU ILE LEU SER ARG SER ILE VAL LYS SEQRES 37 A 531 ARG TRP ALA ASN PHE ALA LYS TYR GLY ASN PRO ASN GLU SEQRES 38 A 531 THR GLN ASN ASN SER THR SER TRP PRO VAL PHE LYS SER SEQRES 39 A 531 THR GLU GLN LYS TYR LEU THR LEU ASN THR GLU SER THR SEQRES 40 A 531 ARG ILE MET THR LYS LEU ARG ALA GLN GLN CYS ARG PHE SEQRES 41 A 531 TRP THR SER PHE PHE PRO LYS VAL LEU GLU MET
HET CCA 566 22
HETNAM CCA 2-BENZOYLOXY-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-3- HETNAM 2 CCA CARBOXYLIC ACID METHYL ESTER
HETSYN CCA COCAINE
FORMUL 2 CCA C17 H22 N O4 1+
HELIX 1 1 LEU A 37 ARG A 41 5 5 HELIX 2 2 PHE A 75 MET A 80 1 6 HELIX 3 3 LEU A 124 ASN A 128 5 5 HELIX 4 4 GLY A 129 ARG A 137 1 9 HELIX 5 5 VAL A 147 LEU A 153 1 7 HELIX 6 6 ASN A 164 ILE A 181 1 18 HELIX 7 7 ALA A 182 PHE A 184 5 3 HELIX 8 8 SER A 197 SER A 209 1 13 HELIX 9 9 GLY A 211 PHE A 216 5 6 HELIX 10 10 LEU A 235 THR A 249 1 15 HELIX 11 11 ASN A 255 ARG A 264 1 10 HELIX 12 12 ASP A 267 GLU A 275 1 9 HELIX 13 13 ALA A 276 VAL A 279 5 4 HELIX 14 14 MET A 301 GLY A 309 1 9 HELIX 15 15 GLY A 325 ALA A 333 1 9 HELIX 16 16 THR A 345 PHE A 357 1 13 HELIX 17 17 SER A 361 THR A 373 1 13 HELIX 18 18 ARG A 380 PHE A 397 1 18 HELIX 19 19 PHE A 397 GLU A 410 1 14 HELIX 20 20 PRO A 430 GLY A 434 5 5 HELIX 21 21 GLU A 440 PHE A 445 1 6 HELIX 22 22 GLY A 446 GLU A 450 5 5 HELIX 23 23 GLU A 450 ASN A 454 5 5 HELIX 24 24 THR A 456 GLY A 477 1 22
SHEET 1 A 3 ILE A 4 THR A 7 0 SHEET 2 A 3 GLY A 10 ARG A 13 -1 O GLY A 10 N THR A 7 SHEET 3 A 3 ILE A 54 ASN A 56 1 O TRP A 55 N ARG A 13 SHEET 1 B11 MET A 15 THR A 18 0 SHEET 2 B11 THR A 23 PRO A 31 -1 O VAL A 24 N LEU A 17 SHEET 3 B11 TYR A 93 ILE A 98 -1 O LEU A 94 N ILE A 30 SHEET 4 B11 ILE A 139 MET A 143 -1 O VAL A 140 N TRP A 97 SHEET 5 B11 ALA A 106 ILE A 112 1 O THR A 107 N ILE A 139 SHEET 6 B11 GLY A 186 GLU A 196 1 N ASN A 187 O ALA A 106 SHEET 7 B11 ARG A 218 GLN A 222 1 O ARG A 218 N LEU A 193 SHEET 8 B11 ILE A 316 ASN A 321 1 O LEU A 317 N LEU A 221 SHEET 9 B11 ALA A 415 PHE A 420 1 O PHE A 416 N VAL A 318 SHEET 1 C 2 SER A 63 CYS A 64 0 SHEET 2 C 2 LEU A 87 SER A 88 1 N SER A 88 O SER A 63 SHEET 1 D 2 THR A 233 SER A 234 0 SHEET 2 D 2 THR A 292 VAL A 293 1 N VAL A 293 O THR A 233
SSBOND 1 CYS A 64 CYS A 91 SSBOND 2 CYS A 251 CYS A 262 SSBOND 3 CYS A 399 CYS A 518
CISPEP 1 ALA A 100 PRO A 101 0 -0.09
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000